Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

9:11 AM ET 8-K
Divestiture Greenpro Capital Corp. GRNQ

Greenpro Capital Divestiture to Ms. Chen Yanhong

Greenpro Capital Corp. completed the sale of its F&A Entities, including Greenpro Resources (HK) Limited and several other subsidiaries, to Ms. Chen Yanhong for approximately $0.45 million in cash. The divested entities primarily provided corporate advisory and company-secretarial services in Hong Kong and China. The company plans to use the proceeds for general corporate purposes and will report these entities as discontinued operations starting in Q3 2026.

Counterparty
Ms. Chen Yanhong
9:02 AM ET 8-K
Loan & Debt RideNow Group, Inc. RDNW

RideNow Group $220M Debt Financing with Centerbridge Partners, L.P. and Alter Domus LLC

RideNow Group, Inc. entered into a new $220 million senior secured term loan credit agreement with affiliates of Centerbridge Partners and Alter Domus to refinance its existing 2021 term loan facility. The new loans mature on September 25, 2031, and carry an interest rate of Adjusted Term SOFR plus 8.375% (subject to a 3.00% floor). The agreement includes a first-priority security interest in substantially all assets and requires the company to maintain specific leverage and liquidity covenants.

Value
$220M
Counterparty
Centerbridge Partners, L.P. and Alter Domus (US) LLC
Term
5 years
9:02 AM ET 8-K
M&A Deal Getty Realty Corp GTY

Getty Realty Signs $261M M&A Deal with Refuel Operating Company, LLC

Getty Realty Corp. acquired a portfolio of 41 convenience store properties from Refuel Operating Company for $260.9 million in a sale-leaseback transaction. The properties, located across four states, were simultaneously leased back to Refuel under four unitary triple net leases with initial 20-year terms. The acquisition was funded through forward equity proceeds, unsecured debt, and property dispositions.

Value
$261M
Counterparty
Refuel Operating Company, LLC
Term
20 years
9:02 AM ET 8-K
Business Update Brookfield Asset Management Ltd. BAM

Brookfield Asset Management Business Update

Brookfield Asset Management is revising its presentation of non-GAAP financial measures, including Fee Revenues and Fee-Bearing Capital, to provide more detail on its partner managers. The company provided recast historical data for the past eight quarters to assist analysts in modeling, though the changes do not impact previously reported Fee-Related Earnings or Distributable Earnings.

8:55 AM ET Form 4
Insider Buying Angel Oak Financial Strategies Income Term Trust FINS

Angel Oak Financial Strategies Income Term Trust Insider Kevin Parks Buys $11.9K of Stock

Kevin Parks bought 1,000 shares of Angel Oak Financial Strategies Income Term Trust at $11.90 a share, worth $11.9K in total on Sep 25, 2026. Shares held after the trade: 7,667 (+15.0%).

Value
$11.9K
Shares
1,000
Price
$11.90
Holding change
+15.0%
Trade date
Sep 25, 2026
8:54 AM ET 8-K
Clinical Trial Data Kodiak Sciences Inc. KOD

Kodiak Sciences Clinical Trial Data

Kodiak Sciences announced that its Phase 3 DAYBREAK study in wet age-related macular degeneration (wAMD) met its primary endpoints for both Zenkuda and tabirafusp-ted. Both drugs demonstrated non-inferiority in vision gains compared to aflibercept, with Zenkuda showing 6-month durability in 54% of patients. The company plans to submit a multi-indication Biologics License Application (BLA) for Zenkuda in the fourth quarter of 2026.

8:54 AM ET 8-K
M&A Deal Lifecore Biomedical, Inc. \De\ LFCR

Lifecore Biomedical, Inc. \De\ Signs $664M M&A Deal with Webster Equity Partners

Lifecore Biomedical has entered into a definitive agreement to be acquired by Webster Equity Partners for up to $663.7 million. Common stockholders will receive $6.28 per share in cash at closing plus contingent value rights (CVRs) worth up to an additional $160 million in aggregate based on performance milestones. The transaction represents a 49.5% premium to the company's last closing price and will result in Lifecore becoming a privately held company.

Value
$664M
Counterparty
Webster Equity Partners
8:53 AM ET 8-K
Leadership Change Core Molding Technologies Inc CMT

Core Molding Technologies Leadership Change

Core Molding Technologies promoted Michael J. Gayford to Chief Operating Officer, effective immediately. Mr. Gayford, who joined the company in 2023 and previously served as Executive Vice President of Operations, will now oversee all North American operations and R&D initiatives. The promotion is part of the company's strategy to drive operational excellence and accelerate growth.

8:52 AM ET 8-K
Executive Compensation Quantum Corp QMCO

Quantum Executive Compensation

Quantum Corporation appointed James C. Clancy as Chief Operating Officer, effective September 28, 2026, following his resignation from the Board of Directors. His compensation package includes a $400,000 base salary, a 60% target bonus, 150,000 RSUs, and 400,000 stock options. The agreement also includes a change-of-control provision providing 12 months of salary and bonus plus full equity acceleration upon involuntary termination.

Counterparty
James C. Clancy
8:51 AM ET 8-K
Executive Compensation Park Aerospace Corp PKE

Park Aerospace Executive Compensation

The Compensation Committee of Park Aerospace Corp. approved a significant increase in the annual base salary for Mark A. Esquivel, the company's President and Chief Operating Officer. His salary will increase from $270,000 to $400,000, effective September 28, 2026.

8:50 AM ET 8-K
Leadership Change Fuller H B Co FUL

Fuller H B Leadership Change

H.B. Fuller Company appointed R. Jeffrey Bailly, former CEO and current Executive Chairman of UFP Technologies, to its Board of Directors as a Class I director. Simultaneously, Ruth S. Kimmelshue resigned from the Board after nine years of service. Mr. Bailly will serve on the Audit and Compensation Committees and receive an annual cash retainer of $100,000 plus equity awards.

8:47 AM ET 8-K
Clinical Trial Data Silexion Therapeutics Corp SLXN

Silexion Therapeutics Clinical Trial Data

Silexion Therapeutics announced positive preclinical translational research findings for its lead RNAi candidate, SIL204, demonstrating a mechanism for systemic uptake in KRAS-driven cancers. The study showed that SIL204 utilizes native serum lipids and lipoprotein pathways for cellular entry and gene silencing without the need for artificial nanoparticles, supporting its upcoming Phase 2/3 clinical program.

8:46 AM ET 8-K
Business Update Bitmine Immersion Technologies, Inc. BMNR

Bitmine Immersion Technologies Business Update

Bitmine Immersion Technologies provided an operational update disclosing that its total crypto, cash, and marketable securities holdings have reached $17.2 billion. The company now holds over 6 million ETH tokens, representing approximately 4.9% of the total ETH supply, and reported that its institutional-grade staking platform MAVAN currently has 5,067,309 staked ETH.

Earnings call
Sep 27, 2026, 3:00 PM ET
8:46 AM ET Form 4
Insider Buying Dynex Capital Inc DX

Dynex Capital Chief Investment Officer Terrence John Connelly Jr. Buys $27.9K of Stock

Terrence John Connelly Jr., Chief Investment Officer, bought 2,500 shares of Dynex Capital Inc at $11.18 a share, worth $27.9K in total on Sep 25, 2026. Shares held after the trade: 58,695 (+4.4%).

Value
$27.9K
Shares
2,500
Price
$11.18
Role
Chief Investment Officer
Holding change
+4.4%
Trade date
Sep 25, 2026
8:45 AM ET Form 4
Insider Buying Anixa Biosciences Inc ANIX

Anixa Biosciences CEO Amit Kumar Buys $19.5K of Stock

Amit Kumar, CEO, bought 7,000 shares of Anixa Biosciences Inc at $2.78 a share, worth $19.5K in total on Sep 24, 2026. Shares held after the trade: 672,000 (+1.1%).

Value
$19.5K
Shares
7,000
Price
$2.78
Role
CEO
Holding change
+1.1%
Trade date
Sep 24, 2026
8:44 AM ET 8-K
Business Update Greenland Energy Co GLND

Greenland Energy Business Update

Greenland Energy Company successfully completed its 2026 environmental baseline field program at the Jameson Land Project in East Greenland. The program, which included soil sampling and wildlife studies, is a required regulatory step to support the Environmental Impact Assessment (EIA) and permitting process for future exploration drilling.

Counterparty
Ministry of Business and Mineral Resources
8:36 AM ET 8-K
Investor Presentation Burke & Herbert Financial Services Corp. BHRB

Burke & Herbert Financial Services Investor Presentation

Burke & Herbert Financial Services Corp. filed a formal fixed income investor presentation to be used in meetings with potential purchasers of its proposed Fixed-to-Floating Rate Subordinated Notes due 2036. The presentation provides strategic and financial updates following the company's merger with LINKBANCORP, Inc.

8:32 AM ET 8-K
M&A Deal Silicon Valley Acquisition Corp. SVAQ

Silicon Valley Acquisition M&A Deal with EigenQ, Inc.

Silicon Valley Acquisition Corp. (SVAQ) entered into a third amendment to its definitive business combination agreement with EigenQ, Inc. The amendment modifies the treatment of certain EigenQ warrants, clarifying they will be exchanged for PubCo warrants upon the closing of the merger. This filing provides a status update on the pending SPAC merger which will result in EigenQ becoming a wholly owned subsidiary of the domesticated Delaware corporation.

Counterparty
EigenQ, Inc.
8:31 AM ET 8-K
Investor Presentation Graphic Packaging Holding Co GPK

Graphic Packaging Holding Investor Presentation

Graphic Packaging Holding Company filed its Fall 2026 Corporate Governance and Stewardship presentation to be used in meetings with investors. The presentation provides a company overview, highlighting its global leadership in sustainable consumer packaging with $8.6 billion in 2025 net sales and over 100 facilities worldwide.

8:31 AM ET 8-K
Leadership Change MongoDB, Inc. MDB

MongoDB Leadership Change

Chirantan “CJ” Desai has resigned as President and CEO of MongoDB to pursue a senior role at Meta Platforms, Inc. The Board has appointed former CEO Dev Ittycheria as Interim President and CEO while it initiates a search for a permanent successor. The company also reaffirmed its previously issued financial guidance for Q3 and full year fiscal 2027.

8:30 AM ET Form 4
Insider Buying Anixa Biosciences Inc ANIX

Anixa Biosciences Insider Arnold M. Baskies Buys $13.8K of Stock

Arnold M. Baskies bought 5,000 shares of Anixa Biosciences Inc at $2.76 a share, worth $13.8K in total on Sep 24, 2026. Shares held after the trade: 140,572 (+3.7%).

Value
$13.8K
Shares
5,000
Price
$2.76
Holding change
+3.7%
Trade date
Sep 24, 2026
8:23 AM ET 8-K
Business Update DeFi Development Corp. DFDV

DeFi Development Business Update

DeFi Development Corp. reported a 2% weekly increase in its Solana (SOL) treasury holdings, reaching a total of 2,538,010 SOL and SOL equivalents valued at approximately $309 million. The company has grown its SOL treasury by 10% since its August 12 earnings update and intends to deploy these assets through staking and validator infrastructure to support its 'Digital Credit 2.0' strategy.

8:20 AM ET 8-K
Loan & Debt Skydance Corp SKYD

Paramount Skydance $44.4B Debt Financing

Paramount Skydance Corporation announced a massive $44.4 billion offering of senior secured first and second lien notes to finance its pending acquisition of Warner Bros. Discovery. The debt package includes both U.S. dollar and euro-denominated notes and is intended to fund the purchase price and repay existing debt. The offering is part of a broader permanent financing plan that includes previously announced term loans and equity financing.

Value
$44.4B
8:18 AM ET 8-K
Deal Termination Cycurion, Inc. CYCU

Cycurion Deal Termination with Yield Point NY LLC

Cycurion, Inc. has terminated its Equity Purchase Agreement with Yield Point NY LLC for convenience, effective September 26, 2026. The company also provided a business update forecasting $843,028 in 2026 revenue from public safety engagements in Chicago and noted it is still awaiting a final delisting decision from the Nasdaq Hearings Panel.

Counterparty
Yield Point NY LLC
8:17 AM ET 8-K
M&A Deal Bold Eagle Acquisition Corp. BEAG

Bold Eagle Acquisition Signs $1.25B M&A Deal with REDLattice

Bold Eagle Acquisition Corp. (BEAG) has entered into a definitive business combination agreement to acquire REDLattice, a cyber intelligence platform for defense and national security, at a pre-money enterprise value of $1.25 billion. The transaction is supported by $335 million in committed capital, including a $60 million common stock investment, and will result in REDLattice becoming a publicly traded company on the Nasdaq under the ticker 'REDL'.

Value
$1.25B
Counterparty
REDLattice (REDL Intermediate Holdings, LLC)
8:17 AM ET 8-K
Clinical Trial Data Transcode Therapeutics, Inc. RNAZ

Transcode Therapeutics Clinical Trial Data

TransCode Therapeutics announced updated Phase 1a clinical trial data for TTX-MC138, showing a 71.4% stable disease rate in patients with advanced solid tumors. The study met its primary safety endpoint with no dose-limiting toxicities reported, and three patients remained progression-free at the one-year mark. The company believes the durability of disease control warrants continued clinical evaluation of the RNA-based therapeutic candidate.

8:16 AM ET 8-K
Clinical Trial Data Adicet Bio, Inc. ACET

Adicet Bio Clinical Trial Data

Adicet Bio announced positive preliminary Phase 1 data for prula-cel in patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN), showing a 50% complete renal response rate and 54% DORIS remission at 12 months. The therapy was generally well tolerated with no Grade 3 or higher CRS and no ICANS, supporting potential outpatient administration. Based on these results, the company plans to initiate pivotal trial start-up activities in the fourth quarter of 2026.

Earnings call
Sep 28, 2026, 8:00 AM ET
8:11 AM ET 8-K
Business Update Fate Therapeutics Inc FATE

Fate Therapeutics Business Update

Fate Therapeutics was awarded a $15 million CLIN2 grant from the California Institute for Regenerative Medicine (CIRM) to support its Phase 2 RECLAIM-LN clinical trial. The funding will advance the development of FT819, an off-the-shelf CAR T-cell therapy for patients with refractory lupus nephritis, a severe manifestation of systemic lupus erythematosus.

Counterparty
California Institute for Regenerative Medicine (CIRM)
8:06 AM ET 8-K
Contract Win Volato Group, Inc. SOAR

Volato Group Wins $1.17B Contract from a large AI customer

Volato Group's subsidiary, Alignment Engine, signed a Master Services Agreement and two initial orders with a large AI customer for dedicated AMD GPU infrastructure in Ohio. The aggregate contract value is approximately $1.17 billion over a four-year take-or-pay term, including $133 million in contractual prepayments. This represents a transformational milestone for the company's AI infrastructure platform.

Value
$1.17B
Counterparty
a large AI customer
Term
48-month term
8:06 AM ET 8-K
Clinical Trial Data 4D Molecular Therapeutics, Inc. FDMT

4D Molecular Therapeutics Clinical Trial Data

4D Molecular Therapeutics announced the enrollment of the first patients in its 4SIGHT Phase 3 clinical trial evaluating 4D-150 for diabetic macular edema (DME). The company also released positive 2-year data from its SPECTRA clinical trial, showing 4D-150 was well tolerated with a 61% reduction in treatment burden compared to standard aflibercept injections.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.